タイプI折り畳み式補正器によるCFTR補正のメカニズム
1Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065, USA.
Cell
|January 7, 2022
まとめ
CFTR補正剤のような小分子チャペロンは 重要なタンパク質領域を安定させ 分解を防止し 病気を引き起こす変異を救います この構造的な洞察は タンパク質の誤折り症の理解と 治療の開発を進めるのです
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- タンパク質の誤折り症は数多く,小分子チャペロンは治療の可能性を秘めています.
- 胞性線維症の治療は,ΔF508変異の折りたたみ欠陥に対処するCFTR補正剤によって革新されました.
研究 の 目的:
- FDAが承認したCFTR補正器の分子作用機構を解明する.
- ルーマカフターとテザカフターの機能の構造的基礎を決定する.
主な方法:
- クリオ電子顕微鏡 (cryo-EM) を使用して,ルマカフターまたはテザカフターとの複合体でCFTRを可視化しました.
- サイト・ディレクテッド・ミュータゲネシスは,薬剤結合部位の機能的意義を調査するために使用された.
主要な成果:
- Cryo-EM構造は,ルマカフトルとテザカフトルの両方がCFTRの第1トランスメブラン領域 (TMD1) 内の水害性ポケットに結合することを明らかにした.
- この結合はTMD1の4つの不安定なヘリクスを結合し,タンパク質の構造を安定させます.
- 特定された結合部位内の変異は薬物の有効性を廃止し,構造的発見の機能的関連性を確認した.
結論:
- CFTR補正剤は,初期の生殖過程でTMD1ドメインを安定させ,ΔF508-CFTR変異体の早期分解を防ぐ.
- この安定化メカニズムは 病気を引き起こす多くの変異をアロステリックに救出し タンパク質の誤折り障害を治療するための経路を提供します
さらに関連する動画
関連する概念動画
Cystic Fibrosis: Management
238
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
238
Cystic Fibrosis: Pathogenesis
390
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
390
Protein Folding Quality Check in the RER
4.0K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
4.0K
Molecular Chaperones and Protein Folding
18.6K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.6K
Mechanisms of Membrane-bending
2.9K
The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
2.9K
The Unfolded Protein Response
5.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.2K


